Failure to withstand oxidative stress induced by phospholipid hydroperoxides as a possible cause of the lens opacities in systemic diseases and ageing.
about
N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient populationCarnosine and Related Peptides: Therapeutic Potential in Age-Related DisordersA new human catalytic antibody Se-scFv-2D8 and its selenium-containing single domains with high GPX activity.Selenium-containing 15-mer peptides with high glutathione peroxidase-like activity.Human catalytic antibody Se-scFv-B3 with high glutathione peroxidase activity.Efficacy of N-acetylcarnosine in the treatment of cataracts.Microsomal glutathione S-transferase 1 in the retinal pigment epithelium: protection against oxidative stress and a potential role in aging.Reconvene and reconnect the antioxidant hypothesis in human health and disease.Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia.Antioxidant capacity of lenses with age-related cataractLutein and zeaxanthin and their potential roles in disease prevention.Effects of fermented Cordyceps sinensis on oxidative stress in doxorubicin treated rats.Ultrastructural analysis of damage to nuclear fiber cell membranes in advanced age-related cataracts from India.Toxicity of linoleic acid hydroperoxide to Saccharomyces cerevisiae: involvement of a respiration-related process for maximal sensitivity and adaptive response.Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutaseCataract formation in Atlantic salmon, Salmo salar L., smolt relative to dietary pro- and antioxidants and lipid level.Phospholipid and protein contents of lens proteolipids in human senile cataract.Novel NAC-loaded poly(lactide-co-glycolide acid) nanoparticles for cataract treatment: preparation, characterization, evaluation of structure, cytotoxicity, and molecular docking studies.A novel dicyclodextrinyl diselenide compound with glutathione peroxidase activity.Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for catBioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform.
P2860
Q24657697-B60F38DA-4AD1-4D63-9665-D4443D7560F8Q26783342-6E385BBB-FFF4-4A20-9505-89E2C343EBD5Q30916976-C94B05F7-B3D0-4CB6-8779-79553A5F1AD8Q31062361-D3506F39-352F-4BC9-B83B-5F861F735ED3Q33346060-42FFD009-E57B-4D47-B1B1-F8DF53140C90Q34127726-6D7EBB4D-470C-40D3-B2A5-15560EA41781Q34313769-B513D96C-AC16-4A38-AFA7-C48FD6BA0CB6Q34405837-A21BBD4E-3507-4DF6-BCFF-563B4980DD34Q35580998-2BA3C6A3-1708-42F9-BF36-D77635DDA9DBQ35738891-1A0F918E-73E8-4F01-8FC5-A842ED8FEF91Q36004071-6719BDFD-33AF-4431-A6AF-AF337D0B1D9AQ36209961-672B0636-CCA7-4B40-9FF6-8C929ADD28B4Q37000355-8C700330-8AF9-491F-B0B5-4E9B3FD1CD31Q39564362-065D89E2-7578-49D8-ADB4-97C6E6121539Q41815238-B538200E-08A7-4D9F-86F2-8BFC7782F071Q44577167-AC6A71E0-BCE6-4230-B529-B4418F454E8DQ44620207-D0B6F780-57A8-4092-9CF5-BD91D2E6F63FQ49453270-CFA0A926-4B30-4E72-BAAB-A721BAD5126CQ50959847-1414A77A-9897-4800-9618-6D4BAAB6E04FQ52608791-503CBB83-3AB4-40C6-890B-9AFA72D8BDE1Q53237437-B969BBD7-9D15-4EAA-921B-513A2B9144AA
P2860
Failure to withstand oxidative stress induced by phospholipid hydroperoxides as a possible cause of the lens opacities in systemic diseases and ageing.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Failure to withstand oxidative ...... systemic diseases and ageing.
@en
Failure to withstand oxidative ...... systemic diseases and ageing.
@nl
type
label
Failure to withstand oxidative ...... systemic diseases and ageing.
@en
Failure to withstand oxidative ...... systemic diseases and ageing.
@nl
prefLabel
Failure to withstand oxidative ...... systemic diseases and ageing.
@en
Failure to withstand oxidative ...... systemic diseases and ageing.
@nl
P1476
Failure to withstand oxidative ...... systemic diseases and ageing.
@en
P2093
M A Babizhayev
P356
10.1016/0925-4439(95)00091-7
P577
1996-03-01T00:00:00Z